- Risk Factors for Failure of Initial Intravenous Immunoglobulin Treatment in Kawasaki Disease
-
Cha S, Yoon M, Ahn Y, Han M, Yoon KL
- KMID: 1785836
- J Korean Med Sci.
- 2008 Aug;23(4):718-722.
- doi: 10.3346/jkms.2008.23.4.718
The aims of this study were to determine the occurrence and variables associated with the initial intravenous immunoglobulin (IVIG) treatment failure in Kawasaki disease (KD) and to categorize differences in... -
- CITED
-
- Close
- SHARE
-
- Close
- Low-dose Methotrexate Therapy for Intravenous Immunoglobulin-resistant Kawasaki Disease
-
Lee TJ, Kim KH, Chun JK, Kim DS
- KMID: 2158188
- Yonsei Med J.
- 2008 Oct;49(5):714-718.
- doi: 10.3349/ymj.2008.49.5.714
PURPOSE: The aim of this study was to evaluate the efficacy of low-dose oral methotrexate (MTX) as a treatment for patients with Kawasaki disease (KD) which was resistant to intravenous... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes of Initial Dexamethasone Treatment Combined with a Single High Dose of Intravenous Immunoglobulin for Primary Treatment of Kawasaki Disease
-
Lim YJ, Jung JW
- KMID: 1799489
- Yonsei Med J.
- 2014 Sep;55(5):1260-1266.
- doi: 10.3349/ymj.2014.55.5.1260
PURPOSE: To investigate the clinical effects of a single high dose intravenous immunoglobulin (IVIG) combined with initial dexamethasone as a primary treatment on Kawasaki disease (KD). MATERIALS AND METHODS: Between January... -
- CITED
-
- Close
- SHARE
-
- Close
